Anavex Life Sciences Corp. is a biopharmaceutical company that specializes in the development of innovative drugs to treat neurodegenerative and neurodevelopmental diseases. With a focus on precision medicine and a pipeline of promising therapies, Anavex is at the forefront of advancing treatments for conditions such as Alzheimer’s and Parkinson’s diseases.
